Treatment of Parkinson's disease and related disorders by novel formulations of the combination carbidopa-levodopa

摘要

An oral antiparkinson drug delivery system consisting of carbidopa and levodopa in immediate and sustained release compartments provides a significant clinical advantage over currently available carbidopa-levodopa preparations.